This invention refers to a stable liquid Etanercept formulation that effectively reduces the production of Etanercept by-products, stably maintaining the pharmaceutical efficacy of the drug during long-term storage. The liquid composition of the invention is provided in pre-filled syringes ready for immediate application to sectors in need of treatment with Etanercept
